INTRODUCTION
asthma, asthma exacerbations
ASTHMA
Severe asthma affects approximately 5%–10% of patients with asthma and is associated with frequent asthma exacerbations, decreased health‐related quality of life, and substantial symptom burden.GSK3772847 (formerly CNTO 7160) is a human monoclonal immunoglobulin G2 (IgG2) sigma antibody that binds domain 1 of the cell surface IL‐33R. Three clinical trials have been conducted previously with GSK3772847 using intravenous (IV) administration (NCT02345928, NCT03207243, NCT03393806)